10% of #breastcancer #patients >=65 yrs old have PGVs w/ #germline #genetictesting, most frequently in BRCA1/2, CHEK2, ATM wjon.org/index.php/wjon… World Journal of Oncology #DrHikmatAbdelRazeq مؤسسة ومركز الحسين للسرطان Invitae Labcorp "GGT should not be overlooked in older BC #patients, as... > 10% of

I have been shouting this from the rooftops to everyone I know. Young breast cancer, which used to be rare, is now common. We have been tracking this for 20 years, but it’s really dramatic over the last 10. Please take note #MedTwitter NO ONE is too young for breast cancer!

📗 Just out in CANCER: We explore the experience of young BC survivors with breastfeeding following tx to inform #survivorship care. Congratulations to Dr. Sella! Thank you to our team and the mentorship of Dr. Shoshana Rosenberg & Dr. Ann Partridge MD, MPH #BreastCancerAwarenessMonth

This recently published📰discusses overcoming challenges in conducting early phase #BreastCancer prevention trials: bazedoxifene and conjugated estrogens vs waitlist control. 🔓pubmed.ncbi.nlm.nih.gov/39293780/#full… ✍️Onalisa Winblad judy garber @DrLauraEsserman Lauren Nye

So invigorated after being invited to speak at Koch Institute at MIT of MIT today on #YoungOnsetCRC . Met so many inspiring researchers, including sangeeta bhatia (same on bsky) and MIT President Emerita Susan Hockfield. Wearing pink for Breast Cancer Awareness Month 🩷 Dana-Farber's Young-Onset Colorectal Cancer Center

In today’s morning sessions, experts discussed the basic biology of LFS as well as promising new therapies. Talks centered around how a better understanding of the Tp53 variant will lead to potential cancer prevention strategies, with scientists discussing strategies for

💫Congratulations Dr. Judy Garber (judy garber), recipient of the Jill Rose Award!💫 The award recognizes Dr. Garber's transformative contributions to #BreastCancer research, which have had a lasting impact on both The Breast Cancer Research Foundation and the entire breast cancer field!

Collaborative project with Nihat Buğra Ağaoğlu Huma Rana, MD, MPH and Busra.Unl and many others is now out in Cancers. This work characterizes CHEK2 variants detected among individuals who underwent genetic testing in Turkey. See: mdpi.com/2072-6694/16/2…

Perspective piece with Parsa Erfani Dayo Fadelu, Ruth Okediji, Vivienne Mulema, Edward Scheffer Cliff & Kwanele Asante-Shongwe on "Advancing Global Pharmacoequity in Oncology" is now published in JAMA Oncology.

📢 Happy to share our last paper on the role of germline BRCA mut in PARPi-related hematologic AEs ⚠️ No differences between carriers vs. non-carriers Thanks to all the coauthors! Eleonora Nicolò Dario Trapani Luca Boscolo Bielo Lorenzo Guidi G Curigliano MD PhD IEO Università degli Studi di Milano

#SABCS24 POSTER | P1 01 09 | Clinicopathological features, treatment patterns and outcomes of germline BRCA mutation (gBRCAm)-associated #BreastCancer compared with sporadic tumors in young women a matched analysis. Stefania Morganti, MD Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 Sara Tolaney Matteo Lambertini, MD PhD judy garber

#SABCS24 POSTER SESSION | P3-09-19 | Tumor genomics in young patients with #MetastaticBreastCancer. #KristenBrantley Romualdo Barroso, MD PhD Brittany Bychkovsky, MD Tari King MD Sara Tolaney Ann Partridge MD, MPH Nancy Lin, MD #AnaGarridoCastro

Check out this recent JAMA Network Open on Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes 🔓pubmed.ncbi.nlm.nih.gov/39745704/ Brittany Bychkovsky, MD Nihat Buğra Ağaoğlu judy garber Huma Rana, MD, MPH

In the latest B-PREP forum Brittany Bychkovsky, MD, MSc (Brittany Bychkovsky, MD) shared insights on the various medications available for those who have a high risk of #BreastCancer. Watch this video to learn more about cancer prevention 👇 youtube.com/watch?v=0eOA_G…

Check out this recently published paper on #CHEK2-related #BreastCancer and the real-world challenges associated with it. 👉pubmed.ncbi.nlm.nih.gov/39966186/ Luiza Weis - Oncologia Brittany Bychkovsky, MD Adela Rodríguez Hernández Romualdo Barroso, MD PhD

New📰on breast imaging recommendations for young females (age < 40 years) with ≥ 20% lifetime #BreastCancer risk: practice patterns at a specialized clinic, read it here👇 pubmed.ncbi.nlm.nih.gov/40450633/ Brittany Bychkovsky, MD judy garber Tari King MD

New 📰: Low Allele Frequency Variants Identified on Germline Multi-Gene Panel Testing for Cancer Predisposition Can Suggest the Presence of Constitutional Mosaicism 🔓pubmed.ncbi.nlm.nih.gov/40260637/ ✍️Adela Rodríguez Hernández Brittany Bychkovsky, MD judy garber

Check out this recent paper on #InflammatoryBreastCancer, it examines the clinicogenomic characterization of #IBC. 👉pubmed.ncbi.nlm.nih.gov/40378057/ @npriedig Brittany Bychkovsky, MD jennifer bellon Tari King MD Eric Winer, MD Lynette Sholl Sara Tolaney Nancy Lin, MD Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 Romualdo Barroso, MD PhD

Dr Hal Burstein (@HaroldBurstein) moderated the Early #BreastCancer Tumor Board at the #HarvardBreastCancerCourse, where breast oncology experts, Dr. E Mittendorf #FainaNakhlis Ada Waks Brittany Bychkovsky, MD, Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 and #JuliaWong, discussed early breast cancer management through

Today was my 4th #pmc2025. I rode 25 miles for my patients, their families and the important cancer research that we do at DFCI. Thank you all for your support. If you would like to donate, my PMC page is at: profile.pmc.org/BB0361